spacer
home > ict > winter 2019 > the balanced approach to optimising clinical trial design and execution
PAY PER VIEW SERVICE

 

Dear guest!

article: The Balanced Approach to Optimising Clinical Trial Design and Execution
format: Adobe Acrobat PDF file
cost: £

spacer

 
News and Press Releases

ICON named best Contract Research Organisation in latest string of awards and recognitions

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device, and government organisations, is proud to announce it was named the “Best Contract Research Organisation” of 2021 during the 17th Annual Scrip Awards ceremony on 2 December.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement